Exploration of selected electronic characteristics of half-sandwich organoruthenium(II) β-diketonate complexes

  • Zuzana Sochorová Vokáčová
  • Iztok Turel
  • Jaroslav V. Burda
Original Paper
First Online:
Received:
Accepted:
  • 48 Downloads
Part of the following topical collections:
  1. P. Politzer 80th Birthday Festschrift

Abstract

Based on experimental work, 12 half-sandwich organoruthenium(II) complexes with p-cymene and various substituted β-diketonates (acac) modified by several functional groups were explored. These complexes were optimized at the B3PW91/6–31 + G(d)/PCM/UFF computational level with the Ru atom described by Stuttgart pseudopotentials. The electron density analysis was performed using the B3LYP/ 6–311++G(2df,2pd)/DPCM/scaled-UAKS model. Electrostatic and averaged local ionization potential were explored and extremes on 0.001 e/a.u.3 isodensity surfaces discussed. Natural population analysis partial charges and electron densities in bond critical point of the key Ru(II) coordination bonds were determined. There was a clear correlation between the results obtained and experimentally known anticancer descriptors.

Graphical abstract

Top Average local ionization potential (ALIP) of half-sandwich organoruthenium(II) β-diketonate complex, bottom IC 50 of b-series for ovarian cancer and Ru–P distances (in Å).

Keywords

Anticancer Ru(II) complexes DFT calculations Half-sandwich complexes 
This is a preview of subscription content, log in to check access

Notes

Acknowledgments

We are grateful for financial support from the Czech Science Foundation (grant no. 16-06240S) and from the Slovenian Research Agency (program grant P1-0175. Calculations were carried out at Faculty Mathematics and Physics, KK2 cluster administered by Štěpán Balcar. The authors also appreciate generous access to computing facilities within the National Grid Infrastructure MetaCentrum, provided under the program ‘Projects of Large Infrastructure for Research, Development, and Innovations’ (LM2010005).

Supplementary material

894_2018_3598_MOESM1_ESM.docx (3.2 mb)
ESM 1 (DOCX 3288 kb)

References

  1. 1.
    Rosenberg B, Van Camp L, Trosko JL, Mansour VH (1969) Platinum drugs; a new class of potent antitumor agents. Nature 222:385–391CrossRefGoogle Scholar
  2. 2.
    Rosenberg B, Van Camp L, Krigas T (1965) Inhibition of cell division in Escherichia Coli by electrolysis products from a platinum electrode. Nature 205(4972):698–699CrossRefGoogle Scholar
  3. 3.
    Kostova I (2006) Ruthenium complexes as anticancer agents. Curr Med Chem 13(9):1085–1107CrossRefGoogle Scholar
  4. 4.
    Suss-Fink G (2010) Arene ruthenium complexes as anticancer agents. Dalton Trans 39(7):1673–1688CrossRefGoogle Scholar
  5. 5.
    Hartinger CG, Dyson PJ (2009) Bioorganometallic chemistry-from teaching paradigms to medicinal applications. Chem Soc Rev 38(2):391–401CrossRefGoogle Scholar
  6. 6.
    Ang WH, Dyson PJ (2006) Classical and non-classical ruthenium-based anticancer drugs: towards targeted chemotherapy. Eur J Inorg Chem:4001–4018Google Scholar
  7. 7.
    Gossens C, Tavernelli I, Rothlisberger U (2005) Rational design of organo-ruthenium anticancer compounds. Chimia 59(3):81–84CrossRefGoogle Scholar
  8. 8.
    Deubel DV, Kai-Chi Lau J (2006) In silico evolution of substrate selectivity: comparison of organometallic ruthenium complexes with the anticancer drug cisplatin. Chem Commun 23:2451–2453CrossRefGoogle Scholar
  9. 9.
    Futera Z, Burda JV (2014) Reaction mechanism of Ru(II) piano-stool complexes: umbrella sampling QM/MM MD study. J Comput Chem 35:1446–1456CrossRefGoogle Scholar
  10. 10.
    Futera Z, Platts JA, Burda JV (2012) Binding of piano-stool Ru(II) complexes to DNA; QM/MM study. J Comput Chem 33:2092–2101CrossRefGoogle Scholar
  11. 11.
    Futera Z, Klenko J, Sponer JE, Sponer J, Burda JV (2009) Interactions of the "piano-stool" [ruthenium(II)(g6-arene)(en)Cl]1 complexes with water and nucleobases; ab initio and DFT study. J Comput Chem 30:1758–1770CrossRefGoogle Scholar
  12. 12.
    Brindell M, Dyduch K, Adamowicz A, Urbanowicz E, Oszajca M, Michalak A, Stochel G, van Eldik R (2014) Base-catalyzed hydrolysis of a RuII-Chloro-dmso complex and its reactivity towards l-methionine. Eur J Inorg Chem 2014:1333–1344CrossRefGoogle Scholar
  13. 13.
    Wang H, DeYonker N, Zhang X, Zhao C, Ji L, Mao Z (2012) Photodissociation of a ruthenium(II) arene complex and its subsequent interactions with biomolecules: a density functional theory study. J Mol Model 18:4675–4686CrossRefGoogle Scholar
  14. 14.
    Wang H, De Yonker N, Gao H, Tan C, Zhang X, Ji L, Zhao C, Mao Z (2012) Aquation and dimerization of osmium(II) anticancer complexes: a density functional theory study. RSC Adv 2:436–446CrossRefGoogle Scholar
  15. 15.
    Mutter ST, Platts JA (2011) Density functional theory studies of interactions of ruthenium arene complexes with base pair steps. J Phys Chem A 115:11293–11302CrossRefGoogle Scholar
  16. 16.
    Serli B, Zangrando E, Gianferrara T, Scolaro C, Dyson PJ, Bergamo A, Alessio E (2005) Is the aromatic fragment of piano-stool ruthenium compounds an essential feature for anticancer activity? The development of new Ru-II-[9]aneS(3) analogues. Eur J Inorg Chem 17:3423–3434CrossRefGoogle Scholar
  17. 17.
    Egger AE, Hartinger CG, Renfrew AK, Dyson PJ (2010) Metabolization of [Ru(η6-C6H5CF3)(pta)Cl2]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligand. J Biol Inorg Chem 15:919–927CrossRefGoogle Scholar
  18. 18.
    Aird R, Cummings J, Ritchie A, Muir M, Morris R, Chen H, Sadler P, Jodrell D (2002) In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer. Br J Cancer 86:1652–1657CrossRefGoogle Scholar
  19. 19.
    Berners-Price SJ, Sadler P (1996) Coordination chemistry of metallodrugs—insights into biological speciation from NMR spectroscopy. Coord Chem Rev 151:1–40Google Scholar
  20. 20.
    Chen H, Parkinson JA, Parsons S, Coxal RA, Gould RO, Sadler P (2002) Organometallic ruthenium(II) diamine anticancer complexes: Arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts. J Am Chem Soc 124(12):3064–3082CrossRefGoogle Scholar
  21. 21.
    Kasparkova J, Marini V, Najajreh Y, Gibson D, Brabec V (2003) DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-Picoline ligand in cell-free media. Relations to their activity in cancer cell lines. Biochemist 42:6321–6332CrossRefGoogle Scholar
  22. 22.
    Novakova O, Chen H, Vrana O, Rodger A, Sadler PJ, Brabec V (2003) DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media. Biochemist 42:11544–11554CrossRefGoogle Scholar
  23. 23.
    Habtemariam A, Melchart M, Fernandez R, Parsons S, Oswald IDH, Parkin A, Fabbiani FPA, Davidson JE, Dawson A, Aird RE, Jodrell DI, Sadler PJ (2006) Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands. J Med Chem 49(23):6858–6868CrossRefGoogle Scholar
  24. 24.
    Wang FY, Habtemariam A, van der Geer EPL, Fernandez R, Melchart M, Deeth RJ, Aird R, Guichard S, Fabbiani FPA, Lozano-Casal P, Oswald IDH, Jodrell DI, Parsons S, Sadler PJ (2005) Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity. Proc Natl Acad Sci USA 102(51):18269–18274CrossRefGoogle Scholar
  25. 25.
    Peacock AFA, Habtemariam A, Fernandez R, Walland V, Fabbiani FPA, Parsons S, Aird RE, Jodrell DI, Sadler PJ (2006) Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. J Am Chem Soc 128(5):1739–1748CrossRefGoogle Scholar
  26. 26.
    Kljun J, Bratsos I, Alessio E, Psomas G, Repnik U, Butinar M, Turk B, Turel I (2013) New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium. Inorg Chem 52:9039–9052CrossRefGoogle Scholar
  27. 27.
    Barragán F, López-Senín P, Salassa L, Betanzos-Lara S, Habtemariam A, Moreno V, Sadler PJ, Marchán V (2011) Photocontrolled DNA binding of a receptor-targeted organometallic ruthenium(II) complex. J Am Chem Soc 133:14098–14108CrossRefGoogle Scholar
  28. 28.
    Wang F, Chen H, Parsons S, Oswald IDH, Davidson JE, Sadler PJ (2003) Kinetics of aquation and anation of ruthenium(ii) arene anticancer complexes, acidity and X-ray structures of aqua adducts. Chem Eur J 9:5810–5820CrossRefGoogle Scholar
  29. 29.
    Chen H, Parkinson JA, Morris RE, Sadler PJ (2003) Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms. J Am Chem Soc 125:173–186CrossRefGoogle Scholar
  30. 30.
    Burda JV, Futera Z, Chval Z (2013) Exploration of various electronic properties along the reaction coordinate for hydration of Pt(II) and Ru(II) complexes; the CCSD, MPx, and DFT computational study. J Mol Model 19(12):5245–5255CrossRefGoogle Scholar
  31. 31.
    Chval Z, Futera Z, Burda JV (2011) Comparison of hydration reactions for “piano-stool” RAPTA-B and [Ru(η6− arene)(en)Cl]+ complexes: density functional theory computational study. J Chem Phys 134:024520CrossRefGoogle Scholar
  32. 32.
    Pavelka M, Burda JV (2007) Pt-bridges in various single-strand and double-helix DNA sequences. DFT and MP2 study of the cisplatin coordination with guanine, adenine, and cytosine. J Mol Model 13:367–379CrossRefGoogle Scholar
  33. 33.
    Burda JV, Runeberg N, Pyykko P (1998) Chemical bonds between noble metals and noble gases. Ab initio study of the neutral diatomics NiXe, PdXe and PtXe. Chem Phys Lett 288(5–6):635–641CrossRefGoogle Scholar
  34. 34.
    Zimmermann T, Leszczynski J, Burda JV (2011) Activation of the cisplatin and transplatin complexes in solution with constant pH and concentration of chloride anions; quantum chemical study. J Mol Model 17:2385–2393CrossRefGoogle Scholar
  35. 35.
    Zeizinger M, Burda JV, Šponer J, Kapsa V, Leszczynski J (2001) A systematic ab initio study of the hydration of selected palladium square-planar complexes. A comparison with platinum analogues. J Phys Chem A 105(34):8086–8092CrossRefGoogle Scholar
  36. 36.
    Seršen S, Kljun J, Kryeziu K, Panchuk R, Alte B, Körner W, Heffeter P, Berger W, Turel I (2015) Structure-related mode-of-action differences of anticancer organoruthenium complexes with β-diketonates. J Med Chem 58(9):3984–3996CrossRefGoogle Scholar
  37. 37.
    Turel I, Kljun J, Perdih F, Morozova E, Bakulev V, Kasyanenko N, Byl JAW, Osheroff N (2010) First ruthenium organometallic complex of antibacterial agent Ofloxacin. Crystal structure and interactions with DNA. Inorg Chem 49(23):10750–10752CrossRefGoogle Scholar
  38. 38.
    Zábojníková T, Cajzl R, Kljun J, Chval Z, Turel I, Burda JV (2016) Interactions of the “piano-stool” [ruthenium(II)(η6-arene)(quinolone)Cl]+ complexes with water; DFT computational study. J Comput Chem 37:1766–1780CrossRefGoogle Scholar
  39. 39.
    Kljun J, Bytzek AK, Kandioller W, Bartel C, Jakupec MA, Hartinger CG, Keppler BK, Turel I (2011) Physicochemical studies and anticancer potency of ruthenium η6-p-cymene complexes containing antibacterial quinolones. Organometallics 30:2506–2512Google Scholar
  40. 40.
    Seršen S, Kljun J, Požgan F, Štefane B, Turel I (2013) Novel organoruthenium(II) β-diketonates as catalysts for ortho-arylation via C–H activation. Organometallics 32:609–616CrossRefGoogle Scholar
  41. 41.
    Wanninger S, Lorenz V, Subhan A, Edelmann FT (2015) Metal complexes of curcumin—synthetic strategies, structures and medicinal applications. Chem Soc Rev 44:4986–5002Google Scholar
  42. 42.
    Kljun J, Turel I (2017) β-Diketones as scaffolds for anticancer drug design—from organic building blocks to natural products and metallodrug components. Eur J Inorg Chem 1655–1666Google Scholar
  43. 43.
    Bradáč O, Zimmermann T, Burda JV (2008) Comparison of the electronic properties, and thermodynamic and kinetic parameters of the aquation of selected platinum(II) derivatives with their anticancer IC50 indexes. J Mol Model 14(8):705–716CrossRefGoogle Scholar
  44. 44.
    Burda JV, Zeizinger M, Sponer J, Leszczynski J (2000) Hydration of cis- and trans-platin: a pseudopotential treatment in the frame of a G3-type theory for platinum complexes. J Chem Phys 113(6):2224–2232CrossRefGoogle Scholar
  45. 45.
    Bradáč O, Zimmermann T, Burda JV (2013) Can Satraplatin be hydrated before the reduction process occurs? The DFT computational study. J Mol Model 19:1669–1168Google Scholar
  46. 46.
    Klamt A (1995) Conductor-like screening model for real solvents: a new approach to the quantitative calculation of solvation phenomena. J Phys Chem 99:2224Google Scholar
  47. 47.
    Klamt A, Schüürmann G (1993) COSMO: a new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient. J Chem Soc Perkin Trans 2:799–805Google Scholar
  48. 48.
    Pavelka M, Burda JV (2008) Molecular Physics 106:2733–2748Google Scholar
  49. 49.
    Politzer P, Laurence PR, Jayasuriya K (1985) Molecular electrostatic potentials: an effective tool for the elucidation of biochemical phenomena. Environ Health Perspect 61:191–202Google Scholar
  50. 50.
    Murray JS, Politzer P (2017) Molecular electrostatic potentials and noncovalent interactions. WIREs Comput Mol Sci 7:1–10CrossRefGoogle Scholar
  51. 51.
    Sjoberg P, Murray JS, Brinck T, Politzer P (1990) Average local ionization energies on the molecular surfaces of aromatic systems as guides to chemical reactivity. Can J Chem 68:1440CrossRefGoogle Scholar
  52. 52.
    Murray JS, Brinck T, Grice ME, Politzer P (1992) Correlations between molecular electrostatic potentials and some experimentally-based indices of reactivity. J Mol Struct THEOCHEM 256:29–45Google Scholar
  53. 53.
    Politzer P, Murray JS, Bulat FA (2010) Average local ionization energy: a review. J Mol Model 16:1731CrossRefGoogle Scholar
  54. 54.
    Foster JP, Weinhold F (1980) Natural hybrid orbitals. J Am Chem Soc 102:7211–7218CrossRefGoogle Scholar
  55. 55.
    Glendening ED, Badenhoop K, Ree AE, Carpenter JE, Bohmann JA, Morales M, Weinhold F (2001) NBO v 5.9 Program 5.0. University of Wisconsin, Madison, Wisconsin 53706: WisconsinGoogle Scholar
  56. 56.
    Bader RFW (1990) Atoms in molecules: a quantum theory. Oxford University Press, OxfordGoogle Scholar
  57. 57.
    Keith TA (2014) Aim all, http://aim.tkgristmill.com

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Chemical Physics and Optics, Faculty of Mathematics and PhysicsCharles UniversityPrague 2Czech Republic
  2. 2.Faculty of Chemistry and Chemical TechnologyUniversity of LjubljanaLjubljanaSlovenia

Personalised recommendations